PCSA logo

Processa Pharmaceuticals (PCSA)

Profile

Full Name

Processa Pharmaceuticals, Inc.

Ticker Symbol

PCSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 7, 2014

Indexes

Not included

Website

http://www.processapharmaceuticals.com

Employees

10

Key Details

Price

$0.26(+2.41%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.87(+54.36% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.26
PCSA price is $0.26

30-Day Relative Volume

4.49
PCSA 30-day relative volume is 4.49

Price Performance

Price Today change

+2.41%
PCSA price is up +2.41% today

Price YTD change

-71.15%
PCSA price is down -71.15% since January 1st

Price 1-year change

-84.73%
PCSA price is down -84.73% year-on-year

Price 3-year change

-99.6%
PCSA price is down -99.6% over the past 3 years

Price Range

Price All-time high

$2695.00
PCSA price is currently -99.99% below its historical high of $2695.00

Price 3-year low

$0.22
PCSA price is currently +15.91% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.34M
PCSA market capitalization is $1.34 million

Market cap 3-year change

-97.32%
PCSA market capitalization is down -97.32% over the past 3 years

Market cap All-time high

$203.96M
PCSA market capitalization is currently -99.34% below its historical high of $203.96 million

Market cap sector rank

5.01%
PCSA market capitalization is higher than 5.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+84.5%
PCSA shares outstanding is up +84.5% year-on-year

Shares Outstanding 3-Year Change

+569.02%
PCSA shares outstanding is up +569.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.33
PCSA beta is 0.33

200-day SMA

$1.09
PCSA price is currently -76.57% below its 200-day simple moving average

50-day SMA

$0.48
PCSA price is currently -46.54% below its 50-day simple moving average

RSI

28.69
PCSA 14-day relative strength index is 28.69

Volume

4.49
PCSA 30-day relative volume is 4.49

ATR

$0.06
PCSA average true range is $0.06

10-day Historical Volatility

207.21%
PCSA 10-day historical volatility is 207.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PCSA annual revenue value is unknown

Revenue Analysts estimate

-
PCSA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PCSA annual revenue 1-year change is unknown

Revenue Sector rank

-
PCSA annual revenue is unknown

EPS

EPS

-$3.87
PCSA annual earnings per share is -$3.87

EPS Analysts estimate

-$2.16
PCSA annual earnings per share is currently +79.17% higher than the consensus analysts' forecast

EPS 1-year change

+54.36%
PCSA annual earnings per share is up +54.36% year-on-year

EPS Sector rank

23.37%
PCSA annual earnings per share is higher than 23.37% of companies in Healthcare sector

Profit

Gross profit

-
PCSA annual gross profit value is unknown

Gross margin

-
PCSA annual gross profit margin value is unknown

Operating profit

-$12.05M
PCSA annual operating income is -$12.05 million

Operating margin

-
PCSA annual operating profit margin value is unknown

Net income

-$11.85M
PCSA annual net profit is -$11.85 million

Net margin

-
PCSA annual net profit margin value is unknown

Expenses

Total expenses

$12.05M
PCSA annual total expenses is $12.05 million

Operating expenses

$12.05M
PCSA annual total operating expenses is $12.05 million

Cost of goods sold

-
PCSA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.78M
PCSA annual SGA is $4.78 million

Depreciation and amortization

$800.00
PCSA annual depreciation & amortization is $800.00

Interest expense

-
PCSA annual interest expense value is unknown

Income tax

-
PCSA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$12.05M
PCSA annual earnings before interest & taxes is -$12.05 million

EBITDA

-$12.05M
PCSA annual EBITDA is -$12.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.23M
PCSA annual total assets is $3.23 million

Non current assets

$1.36M
PCSA annual long term assets is $1.36 million

Current assets

$1.87M
PCSA annual total current assets is $1.87 million

Cash and cash equivalents

$1.19M
PCSA annual cash & cash equivalents is $1.19 million

Accounts receivable

-
PCSA annual accounts receivable value is unknown

Inventory

-
PCSA annual inventory value is unknown

Liabilities

Total liabilities

$1.53M
PCSA annual total liabilities is $1.53 million

Long term liabilities

$500.00
PCSA annual total long term liabilities is $500.00

Current liabilities

$1.53M
PCSA annual total current liabilities is $1.53 million

Accounts payable

$880.90K
PCSA annual accounts payable is $880.90 thousand

Debt

Total debt

$73.50K
PCSA annual total debt is $73.50 thousand

Total debt 1-year change

-51.16%
PCSA annual total debt is down -51.16% year-on-year

Long term debt

$500.00
PCSA annual long term debt is $500.00

Short term debt

$73.00K
PCSA annual short term debt is $73.00 thousand

Equity & Capital

Shareholders equity

$1.70M
PCSA annual stockholders equity is $1.70 million

Book value

$1.70M
PCSA annual book value is $1.70 million

Retained earnings

-$87.22M
PCSA annual retained earnings is -$87.22 million

Working capital

$341.00K
PCSA annual working capital is $341.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.24M
PCSA annual cash flow from operations is -$11.24 million

Cash from operations 1-year change

-39.46%
PCSA annual cash flow from operations is down -39.46% year-on-year

Cash from investing

-$3200.00
PCSA annual cash flow from investing activities is -$3200.00

Cash from investing 1-year change

-14.29%
PCSA annual cash flow from investing activities is down -14.29% year-on-year

Cash from financing

$7.73M
PCSA annual cash flow from financing activities is $7.73 million

Cash from financing 1-year change

+23.37%
PCSA annual cash flow from financing activities is up +23.37% year-on-year

CAPEX

CAPEX

-
PCSA annual capital expenditures value is unknown

CAPEX 1-year change

-
PCSA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$11.25M
PCSA annual free cash flow is -$11.25 million

Free cash flow 1-year change

-39.45%
PCSA annual free cash flow is down -39.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PCSA annual gross profit margin value is unknown

Operating margin

-
PCSA annual operating profit margin value is unknown

Net margin

-
PCSA annual net profit margin value is unknown

ROA & ROE

ROA

-366.96%
PCSA annual return on assets is -366.96%

ROE

-698.63%
PCSA annual return on equity is -698.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PCSA price to earnings ratio value is unknown

PE ratio Sector rank

-
PCSA price to earnings ratio is unknown

PB Ratio

PB ratio

0.79
PCSA price to book ratio is 0.79

PB ratio Sector rank

40.05%
PCSA price to book ratio is higher than 40.05% of companies in Healthcare sector

PS Ratio

PS ratio

-
PCSA price to sales ratio value is unknown

PS ratio Sector rank

-
PCSA price to sales ratio is unknown

Enterprise value

Enterprise value

$225.85K
PCSA enterprise value is $225.85 thousand

Enterprise value Sector rank

12.8%
PCSA enterprise value is higher than 12.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.02
PCSA EV/EBITDA is -0.02

EV/EBITDA Sector rank

63.6%
PCSA EV/EBITDA is higher than 63.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.22
PCSA annual current ratio is 1.22

Quick ratio

-
PCSA annual quick ratio value is unknown

Leverage

Debt to equity

0.04
PCSA annual debt to equity ratio is 0.04

Interest coverage ratio

-
PCSA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PCSA piotroski f-score value is unknown

Altman Z-Score

-
PCSA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 5, 24 HC Wainwright & Co.
Buy
Aug 20, 24 HC Wainwright & Co.
Buy
Aug 19, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 12, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Apr 25, 24 HC Wainwright & Co.
Buy
Mar 6, 24 Benchmark
Speculative Buy
Nov 17, 23 Maxim Group
Hold
Apr 4, 23 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

UPC logo
Universe Pharmaceuticals (UPC)
APDN logo
Applied DNA Sciences (APDN)
YCBD logo
cbdMD (YCBD)
VINC logo
Vincerx Pharma (VINC)
NAYA Biosciences (NAYA)
PTPI logo
Petros Pharmaceuticals (PTPI)
BDRX logo
Biodexa Pharmaceuticals (BDRX)
ISPC logo
iSpecimen (ISPC)
BPTH logo
Bio-Path Holdings (BPTH)
  • What is the ticker symbol for Processa Pharmaceuticals?
  • Does Processa Pharmaceuticals pay dividends?
  • What sector is Processa Pharmaceuticals in?
  • What industry is Processa Pharmaceuticals in?
  • What country is Processa Pharmaceuticals based in?
  • When did Processa Pharmaceuticals go public?
  • Is Processa Pharmaceuticals in the S&P 500?
  • Is Processa Pharmaceuticals in the NASDAQ 100?
  • Is Processa Pharmaceuticals in the Dow Jones?
  • When was Processa Pharmaceuticals's last earnings report?
  • When does Processa Pharmaceuticals report earnings?
  • Should I buy Processa Pharmaceuticals stock now?

What is the ticker symbol for Processa Pharmaceuticals?

The ticker symbol for Processa Pharmaceuticals is NASDAQ:PCSA

Does Processa Pharmaceuticals pay dividends?

No, Processa Pharmaceuticals does not pay dividends

What sector is Processa Pharmaceuticals in?

Processa Pharmaceuticals is in the Healthcare sector

What industry is Processa Pharmaceuticals in?

Processa Pharmaceuticals is in the Biotechnology industry

What country is Processa Pharmaceuticals based in?

Processa Pharmaceuticals is headquartered in United States

When did Processa Pharmaceuticals go public?

Processa Pharmaceuticals's initial public offering (IPO) was on March 7, 2014

Is Processa Pharmaceuticals in the S&P 500?

No, Processa Pharmaceuticals is not included in the S&P 500 index

Is Processa Pharmaceuticals in the NASDAQ 100?

No, Processa Pharmaceuticals is not included in the NASDAQ 100 index

Is Processa Pharmaceuticals in the Dow Jones?

No, Processa Pharmaceuticals is not included in the Dow Jones index

When was Processa Pharmaceuticals's last earnings report?

Processa Pharmaceuticals's most recent earnings report was on Oct 30, 2024

When does Processa Pharmaceuticals report earnings?

The next expected earnings date for Processa Pharmaceuticals is May 9, 2025

Should I buy Processa Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page